Top Markets
Coin of the day
N4 Pharma Plc N4 Pharma Plc

N4 Pharma Plc

N4P
Rank in Stocks #20665
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica... N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Share Price
$0.00646333
Market Cap
$53.79K
Change (1 day)
0.00%
Change (1 year)
4.94%
Country
GB
Trade N4 Pharma Plc (N4P)

Category

P/B ratio for N4 Pharma Plc (N4P)
P/B ratio as of March 2026 TTM: 1.55
According to N4 Pharma Plc latest financial reports and stock price the company's current price-to-book ratio (TTM) is 1.55. At the end of 2023 the company had a P/B ratio of 1.83.
P/B ratio history for N4 Pharma Plc from 2000 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 1.55 -43.83%
2024 2.76 50.71%
2023 1.83 10.86%
2022 1.65 -56.35%
2021 3.78 21.59%
2020 3.11 11.54%
2019 2.79 -70.64%
2018 9.50 84.96%
2017 5.14 135.16%
2016 2.18 449.11%
2015 0.40 -68.85%
2014 1.28 88.45%
2013 0.68 2.99%
2012 0.66 -13.38%
2011 0.76 -54.80%
2010 1.68 35.93%
2009 1.24 -44.36%
2008 2.22 44.89%
2007 1.53 -22.69%
2006 1.98 -76.85%
2005 8.57 76.86%
2004 4.85 -213.33%
2003 -4.28 107.38%
2002 -2.06 217.27%
2001 -0.65 -71.69%
2000 -2.30 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
1.6392 5.74%
DE
2.8872 86.25%
FR
1.1725 -24.36%
JP
15.2101 881.17%
US
2.1293 37.36%
GB